CuraVAC

Best option for granulation-tissue formation

  • Superior barrier with prompt gelation in situ
  • Advanced mucous membrane adhesiveness
  • Antibacterial and local hemostasis
  • Complete excretion within 3 weeks

Mechanism

Diabetic foot ulcer, Pressure ulcer, Burn, Flaps and grafts, Dehisced wound. Various acute and chronic wounds


Experimentation


Specification

Ref.No Description Packing Unit
CUVK0100 CuraVAC(08-852)
K2,S,100*75*30mm
1 EA /1 BOX
CUVK0300 CuraVAC(08-852)
K2,S,160*125*30mm
1 EA /1 BOX
CUVK0500 CuraVAC(08-852)
K2,L,260*150*30mm
1 EA /1 BOX
CUVB0300 CuraVAC(08-852)
Bridge,M,160*125*30mm
1 EA /1 BOX
CUVB0500 CuraVAC(08-852)
Bridge,L,260*125*30mm
1 EA /1 BOX
CUVS4300 CuraVAC(08-852)
160*125*30mm
1 EA /1 BOX
CUVS4500 CuraVAC(08-852)
260*150*30mm
1 EA /1 BOX

Research Information

  • Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot.
  • Cyclic negative pressure wound therapy: an alternative mode to intermittent system
  • Treatment of a Chronic Gouty Ulcer on the Lateral Malleolus with Vacuum-Assisted Closure (VAC) Therapy.
  • Acute Postpneumonectomy Empyema with Bronchopleural Fistula Treated with Vacuum-assisted Closure Device.
  • Negative-Pressure Wound Therapy Using Modified Vacuum-Assisted Closure in Patients with Diabetic Foot Ulcers.
  • Efficacy of Curavac® System to Enhance Skin Graft Survival in Chronic Intractable Wound.
  • The effect and safety after extended use of continuous negative pressure of 75 mmHg over mesh and allodermis graft on open sternal wound from oversized heart transplant in a 3-month-old infant.